Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03349697 · ClinicalTrials.gov registry record · Phase 2

Phyllantus Amarus for the Protection of Liver Health

A Phase 2 study of Healthy, sponsored by Biotropics Malaysia Berhad.

Completed
Registry status
Phase 2
Development phase
15
Enrollment target
1
Study location

NCT03349697: Completed Phase 2 study of Healthy, sponsored by Biotropics Malaysia Berhad.

NCT03349697 is a Phase 2 study of Healthy that has completed, run by Biotropics Malaysia Berhad. The registered enrollment target is 15 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03349697, a Phase 2 study of Healthy, has completed, sponsored by Biotropics Malaysia Berhad.

COMPLETED
Registry status
Phase 2
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, double-blind, placebo controlled crossover study. The purpose of this study is to assess the ability of Phyllantus amarus to protect the liver against temporary stress including oxidative stress induced by alcohol consumption.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Phyllantus amarus

Study Locations (1)

California

  • Medicus Research, LLC - Northridge

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2010-07-13
Est. Completion 2010-10-16
Phase Phase 2

Sponsor

Biotropics Malaysia Berhad

1 total trials

What the Registry Record Tells You About NCT03349697

The ClinicalTrials.gov registry entry for NCT03349697 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Biotropics Malaysia Berhad, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03349697 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03349697 about?

NCT03349697 is a clinical study titled "Phyllantus Amarus for the Protection of Liver Health". This study is a randomized, double-blind, placebo controlled crossover study. The purpose of this study is to assess the ability of Phyllantus amarus to protect the liver against temporary stress including oxidative stress induced by alcohol consumption.

What is the current status of trial NCT03349697?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2010-07-13. Estimated completion is 2010-10-16.

What conditions does trial NCT03349697 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03349697?

The interventions under investigation include: Placebo (OTHER), Phyllantus amarus (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03349697?

This trial is sponsored by Biotropics Malaysia Berhad, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03349697 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.